← back to search

April Frazier

La Jolla Alcohol Research · US
🔎 Find collaborators in Infectious Diseases · Neurology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Infectious Diseases · Neurology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Allergic Rhinitis and Sensitization, Neuroinflammation and Neurodegeneration Mechanisms, and Parkinson's Disease Mechanisms and Treatments.
h-index
25
citations
14,729
works
107
NIH funding
primary concept
Biology
email

Recent publications

Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis
Nature 2025cited by 12position: middledoi
T cell responses towards PINK1 and α-synuclein are elevated in prodromal Parkinson’s disease
npj Parkinson s Disease 2025cited by 6position: middledoi
SARS-CoV-2 breakthrough infections enhance T cell response magnitude, breadth, and epitope repertoire
Cell Reports Medicine 2024cited by 28position: middledoi
PINK1 is a target of T cell responses in Parkinson’s disease
Journal of Clinical Investigation 2024cited by 21position: middledoi
Targets and cross-reactivity of human T cell recognition of common cold coronaviruses
Cell Reports Medicine 2023cited by 35position: middledoi
T cell reactivity to Bordetella pertussis is highly diverse regardless of childhood vaccination
Cell Host & Microbe 2023cited by 22position: middledoi
Humoral and cellular immune memory to four COVID-19 vaccines
Cell 2022cited by 591position: middledoi
Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status
Cell Host & Microbe 2022cited by 51position: middledoi
Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures
npj Parkinson s Disease 2022cited by 47position: middledoi
Immunological memory to common cold coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemic
Cell Host & Microbe 2022cited by 36position: middledoi
Unaltered T cell responses to common antigens in individuals with Parkinson's disease
Journal of the Neurological Sciences 2022cited by 16position: middledoi
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Science 2021cited by 2,998position: middledoi
Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
Cell Reports Medicine 2021cited by 674position: middledoi
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
Cell Reports Medicine 2021cited by 575position: middledoi
The TCR repertoire of α-synuclein-specific T cells in Parkinson’s disease is surprisingly diverse
Scientific Reports 2021cited by 36position: middledoi
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Cell 2020cited by 4,023position: middledoi
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Cell 2020cited by 1,969position: middledoi
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Science 2020cited by 1,282position: middledoi
α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
Nature Communications 2020cited by 389position: middledoi
Immunological memory to SARS-CoV-2 assessed for up to eight months after infection.
2020cited by 133position: middle
Widespread Tau-Specific CD4 T Cell Reactivity in the General Population
The Journal of Immunology 2019cited by 42position: middledoi
Allergen content in German cockroach extracts and sensitization profiles to a new expanded set of cockroach allergens determine in vitro extract potency for IgE reactivity
Journal of Allergy and Clinical Immunology 2018cited by 56position: middledoi
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Nature 2017cited by 876position: middledoi
Potent Neutralization of Vaccinia Virus by Divergent Murine Antibodies Targeting a Common Site of Vulnerability in L1 Protein
Journal of Virology 2014cited by 64position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alessandro Sette · University of California System22 papers (2017–2025)Bjoern Peters · La Jolla Institute for Immunology13 papers (2014–2023)Daniela Weiskopf · La Jolla Institute for Immunology12 papers (2017–2023)Alba Grifoni · La Jolla Institute for Immunology12 papers (2020–2024)Jennifer M. Dan · University of California System10 papers (2020–2024)Shane Crotty · La Jolla Institute for Immunology10 papers (2014–2024)José Mateus · Pontificia Universidad Javeriana9 papers (2020–2022) · 9 papers (2017–2025)David Sulzer · Columbia University Irving Medical Center9 papers (2017–2025)S. Mallal · Tennessee Department of Health8 papers (2017–2025)Elizabeth J. Phillips · University of Manitoba8 papers (2017–2025)John Sidney · La Jolla Institute for Immunology8 papers (2017–2025)Davey M. Smith · Imperial College London7 papers (2020–2022)Stephen A. Rawlings · MaineHealth7 papers (2020–2022)Ricardo da Silva Antunes · University of California San Diego7 papers (2021–2024)Sydney I. Ramirez · Center for Global Health7 papers (2020–2022)Alison Tarke · University of Genoa6 papers (2021–2024)Esther Dawen Yu · La Jolla Institute for Immunology6 papers (2020–2022)Amy W. Amara · University of Alabama at Birmingham6 papers (2019–2025)David G. Standaert · University of Alabama at Birmingham6 papers (2019–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Infectious Diseases · Neurology →